Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review

Current therapies for Parkinson’s disease (PD) are palliative, of which the levodopa/carbidopa therapy remains the primary choice but is unable to modulate the progression of neurodegeneration. Due to the complication of such a multifactorial disorder and significant limitations of the therapy, nume...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Neurodegener
Main Authors: Behl, Tapan, Kaur, Gagandeep, Fratila, Ovidiu, Buhas, Camelia, Judea-Pusta, Claudia Teodora, Negrut, Nicoleta, Bustea, Cristiana, Bungau, Simona
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7809876/
https://ncbi.nlm.nih.gov/pubmed/33446243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-020-00226-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki